Regulus Therapeutics SG&A Expense (Quarterly) Trends

Regulus Therapeutics Inc (RGLS)

2.65 -0.04 (-1.49%) USD | NASDAQ | May 03, 16:00

2.65 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2011. Upgrade now.

Date	Value
December 31, 2023	2.537M
September 30, 2023	2.637M
June 30, 2023	2.339M
March 31, 2023	2.444M
December 31, 2022	2.219M
September 30, 2022	2.253M
June 30, 2022	2.467M
March 31, 2022	2.89M
December 31, 2021	2.551M
September 30, 2021	2.504M
June 30, 2021	2.488M
March 31, 2021	2.478M
December 31, 2020	2.078M
September 30, 2020	2.059M
June 30, 2020	2.254M
March 31, 2020	2.422M
December 31, 2019	2.363M
September 30, 2019	2.571M
June 30, 2019	2.85M
March 31, 2019	3.533M
December 31, 2018	2.745M
September 30, 2018	2.993M
June 30, 2018	3.349M
March 31, 2018	3.773M
December 31, 2017	3.259M

Date	Value
September 30, 2017	2.736M
June 30, 2017	7.057M
March 31, 2017	3.959M
December 31, 2016	4.782M
September 30, 2016	4.842M
June 30, 2016	3.664M
March 31, 2016	5.103M
December 31, 2015	5.427M
September 30, 2015	4.245M
June 30, 2015	5.814M
March 31, 2015	3.644M
December 31, 2014	3.278M
September 30, 2014	2.569M
June 30, 2014	2.954M
March 31, 2014	2.732M
December 31, 2013	1.884M
September 30, 2013	1.917M
June 30, 2013	1.723M
March 31, 2013	1.905M
December 31, 2012	1.934M
September 30, 2012	1.093M
June 30, 2012	0.984M
March 31, 2012	0.921M
December 31, 2011	0.773M
September 30, 2011	0.907M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.059M

Minimum

Sep 2020

2.89M

Maximum

Mar 2022

2.442M

Average

2.467M

Median

Jun 2022

SG&A Expense (Quarterly) Benchmarks